Emcure Pharmaceuticals Limited (NSE:EMCURE)
India flag India · Delayed Price · Currency is INR
1,075.00
+2.60 (0.24%)
Last updated: Apr 1, 2025

Emcure Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Debt / Equity Ratio
0.280.750.881.051.041.17
Upgrade
Debt / EBITDA Ratio
0.881.911.991.681.933.31
Upgrade
Debt / FCF Ratio
-2.846.555.694.266.04
Upgrade
Asset Turnover
-0.920.940.910.790.86
Upgrade
Inventory Turnover
-1.661.541.471.391.73
Upgrade
Quick Ratio
-0.750.720.510.580.45
Upgrade
Current Ratio
-1.331.271.161.090.93
Upgrade
Return on Equity (ROE)
-18.28%23.59%31.35%27.90%5.19%
Upgrade
Return on Assets (ROA)
-7.92%9.04%10.54%9.43%4.14%
Upgrade
Return on Capital (ROIC)
-10.98%12.36%14.80%13.20%5.75%
Upgrade
Return on Capital Employed (ROCE)
-20.00%25.20%35.00%28.40%12.70%
Upgrade
Payout Ratio
0.00%10.89%6.80%8.19%4.61%54.08%
Upgrade
Buyback Yield / Dilution
-2.25%-0.01%----
Upgrade
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.